MedPath
FDA Approval

Fludeoxyglucose

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Kreitchman PET Center
DUNS: 010861487
Effective Date
January 9, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fludeoxyglucose (18F)(100 mCi in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Kreitchman PET Center

Kreitchman PET Center

010861487

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fludeoxyglucose F18

Product Details

NDC Product Code
62072-008
Application Number
ANDA203942
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
January 22, 2020
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACT
Code: 0Z5B2CJX4DClass: ACTIBQuantity: 100 mCi in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 4.5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath